Yantai Dongcheng Pharmaceutical Co Ltd (002675)

Shenzhen
Currency in CNY
15.23
-0.15(-0.98%)
Delayed Data·
002675 Scorecard
Full Analysis
Trading at a high earnings multiple
002675 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.1915.44
52 wk Range
11.3316.35
Key Statistics
Edit
Bid/Ask
15.22 / 15.23
Prev. Close
15.38
Open
15.3
Day's Range
15.19-15.44
52 wk Range
11.33-16.35
Volume
2.35M
Average Vol. (3m)
11.71M
1-Year Change
10.87%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002675 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.50
Upside
+1.77%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry
No news in this category
Looks like there are no results in this news category

Yantai Dongcheng Pharmaceutical Co Ltd Company Profile

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection, as well as ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule. In addition, it offers Technetium [99Tc] Methylene Diphosphonate Injection; Technetium [99mTc] Tc labeled tracers; 2-[18F]FDG that helps to detect the activity of tumor cells; sodium iodide [131I] oral solution; iodine [125I] seed use to treat internal radiation of various malignant tumors; [14C]Urea capsule; and jiabaolin glucosamine chondroitin sulfate capsule. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.

Employees
2469
Market
China

Compare 002675 to Peers and Sector

Metrics to compare
002675
Peers
Sector
Relationship
P/E Ratio
88.1x35.6x−0.5x
PEG Ratio
−2.470.460.00
Price / Book
2.8x2.5x2.6x
Price / LTM Sales
4.4x6.8x3.1x
Upside (Analyst Target)
4.0%11.8%48.3%
Fair Value Upside
Unlock11.9%7.6%Unlock

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.50
(+1.77% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.17%
Dividend Yield
1.34%
Industry Median 1.47%
Annualized Payout
0.21
Paid unevenly
5-Years Growth
-20.38%
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.16 / --
Revenue / Forecast
687.00M / --
EPS Revisions
Last 90 days

002675 Income Statement

FAQ

What Is the Yantai Dongcheng Pharma (002675) Stock Price Today?

The Yantai Dongcheng Pharma stock price today is 15.23

What Stock Exchange Does Yantai Dongcheng Pharma Trade On?

Yantai Dongcheng Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Yantai Dongcheng Pharma?

The stock symbol for Yantai Dongcheng Pharma is "002675."

Does Yantai Dongcheng Pharma Pay Dividends? What’s The Current Dividend Yield?

The Yantai Dongcheng Pharma dividend yield is 1.33%.

What Is the Yantai Dongcheng Pharma Market Cap?

As of today, Yantai Dongcheng Pharma market cap is 12.61B.

What Is Yantai Dongcheng Pharma's Earnings Per Share (TTM)?

The Yantai Dongcheng Pharma EPS (TTM) is 0.17.

When Is the Next Yantai Dongcheng Pharma Earnings Date?

Yantai Dongcheng Pharma will release its next earnings report on Aug 22, 2025.

From a Technical Analysis Perspective, Is 002675 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Yantai Dongcheng Pharma Stock Split?

Yantai Dongcheng Pharma has split 2 times.

How Many Employees Does Yantai Dongcheng Pharma Have?

Yantai Dongcheng Pharma has 2469 employees.

What is the current trading status of Yantai Dongcheng Pharma (002675)?

As of Jun 13, 2025, Yantai Dongcheng Pharma (002675) is trading at a price of 15.23, with a previous close of 15.38. The stock has fluctuated within a day range of 15.19 to 15.44, while its 52-week range spans from 11.33 to 16.35.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.